-
1 Comment
Medius Holdings Co., Ltd is currently in a long term uptrend where the price is trading 13.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Medius Holdings Co., Ltd's total revenue rose by 26.4% to $63B since the same quarter in the previous year.
Its net income has increased by 244.6% to $728M since the same quarter in the previous year.
Based on the above factors, Medius Holdings Co., Ltd gets an overall score of 4/5.
| Industry | Medical Instruments & Supplies |
|---|---|
| ISIN | JP3254190006 |
| Sector | Healthcare |
| Exchange | TSE |
| CurrencyCode | JPY |
| Beta | 0.48 |
|---|---|
| Target Price | None |
| Dividend Yield | 4.0% |
| PE Ratio | 20.79 |
| Market Cap | 21B |
Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was incorporated in 2009 and is based in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3154.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
